| Sample name | Tirzepatide |
|---|---|
| Strength | 10mg |
| Lot / batch | Z51-Z12 |
| Purity (HPLC) | 94.95% |
| Content measured | 14.15 mg per vial — 141.5% of the 10 mg label claim |
| Laboratory verdict | Does not pass (purity 94.95% is below the laboratory’s 97% acceptance limit) |
| Report date | 2026-10-13 |
| Reference | tr30b |
| Laboratory | Premier Analytical Sciences |
We paid for this test. PeptiWorks commissioned and paid for the analysis of lot Z51-Z12. The laboratory record carries the name Zeus BioLabs (Morristown, New Jersey), a third party, at our request. That name is what you will see if you open the register. It is not the company you are buying from.
Why: our Hong Kong entity is a peptide trading company. A laboratory register that lists peptide sellers as buyers becomes a map of who to target, and we would rather not hand that over. So the submission goes in under a customer’s name. That is a commercial choice about anonymity, and you should know it is a choice.
What it changes: the name in the client field. What it does not change: the laboratory received the sample sealed, ran it, and published the result. The purity and the measured content below are its numbers. Neither we nor Zeus BioLabs can edit a published record — the register is one-way.
Check it yourself: premieranalytical.com/verify/PAS-2026-3754. You will see Zeus BioLabs in the client field. You will also see the laboratory’s own verdict, including on the lots where that verdict is not flattering.